{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:04:44Z","timestamp":1790899484040,"version":"4.1.0"},"reference-count":138,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) infection is currently a great cause of concern for the healthcare sector around the globe. SARS-CoV-2 is an RNA virus that causes a serious infection that is associated with numerous adverse effects and multiple complications associated with different organs and systems during its pathogenic cycle in humans. Individuals affected by COVID-19, especially elderly populations and immunocompromised people, are greatly vulnerable to opportunistic fungal pathogens. Aspergillosis, invasive candidiasis, and mucormycosis are widespread fungal coinfections in COVID-19 patients. Other fungal infections that are rare but are exhibiting increased incidence in the current scenario include infections caused by Pneumocystis jirovecii, Histoplasma sp., Cryptococcus sp., etc. By producing virulent spores, these pathogens increase the severity of the disease and increase the morbidity and fatality rates in COVID-19 patients globally. These infections generally occur in patients recovering from COVID-19 infection, resulting in rehospitalization. Older and immunocompromised individuals are at higher risk of developing opportunistic fungal infections. This review focuses on understanding the opportunistic fungal infections prevalent in COVID-19 patients, especially elderly people. We have also highlighted the important preventive methods, diagnostic approaches, and prophylactic measures for fungal infections.<\/jats:p>","DOI":"10.3390\/vaccines11030555","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T03:00:38Z","timestamp":1677553238000},"page":"555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Post-COVID-19 Fungal Infection in the Aged Population"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7701-8597","authenticated-orcid":false,"given":"Vivek","family":"Chavda","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Ahmedabad 380009, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7113-7720","authenticated-orcid":false,"given":"Toshika","family":"Mishra","sequence":"additional","affiliation":[{"name":"Science, Innovation, and Society Research Lab. 115, Department of Biotechnology, Hexagon (SMV), Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4474-1479","authenticated-orcid":false,"given":"Sathvika","family":"Kamaraj","sequence":"additional","affiliation":[{"name":"Science, Innovation, and Society Research Lab. 115, Department of Biotechnology, Hexagon (SMV), Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9773-1712","authenticated-orcid":false,"given":"Swati","family":"Punetha","sequence":"additional","affiliation":[{"name":"Science, Innovation, and Society Research Lab. 115, Department of Biotechnology, Hexagon (SMV), Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-0764","authenticated-orcid":false,"given":"Oishani","family":"Sengupta","sequence":"additional","affiliation":[{"name":"Science, Innovation, and Society Research Lab. 115, Department of Biotechnology, Hexagon (SMV), Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6541-1981","authenticated-orcid":false,"given":"Yash","family":"Joshi","sequence":"additional","affiliation":[{"name":"Science, Innovation, and Society Research Lab. 115, Department of Biotechnology, Hexagon (SMV), Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4694-1944","authenticated-orcid":false,"given":"Suneetha","family":"Vuppu","sequence":"additional","affiliation":[{"name":"Science, Innovation, and Society Research Lab. 115, Department of Biotechnology, Hexagon (SMV), Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3129-6468","authenticated-orcid":false,"given":"Dixa","family":"Vaghela","sequence":"additional","affiliation":[{"name":"Pharmacy Section, L.M. College of Pharmacy, Ahmedabad 380009, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8106-9066","authenticated-orcid":false,"given":"Lalitkumar","family":"Vora","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Queen\u2019s University Belfast, Belfast BT9 7BL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2022.888452","article-title":"Fungal Infection in Co-Infected Patients With COVID-19: An Overview of Case Reports\/Case Series and Systematic Review","volume":"13","author":"Seyedjavadi","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s42399-020-00363-4","article-title":"Comorbidity and Its Impact on Patients with COVID-19","volume":"2","author":"Sanyaolu","year":"2020","journal-title":"SN Compr. Clin. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.15190\/d.2021.5","article-title":"High Mortality Co-Infections of COVID-19 Patients: Mucormycosis and Other Fungal Infections","volume":"9","author":"Bhatt","year":"2021","journal-title":"Discoveries"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.33073\/pjm-2021-039","article-title":"Fungal Infections in COVID-19 Intensive Care Patients","volume":"70","author":"Coskun","year":"2021","journal-title":"Pol. J. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","article-title":"Bacterial and Fungal Coinfection among Hospitalized Patients with COVID-19: A Retrospective Cohort Study in a UK Secondary-Care Setting","volume":"26","author":"Hughes","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2147\/IDR.S314029","article-title":"Coinfections in Patients Hospitalized with COVID-19: A Descriptive Study from the United Arab Emirates","volume":"14","author":"Senok","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of Co-Infections and Superinfections in Hospitalized Patients with COVID-19: A Retrospective Cohort Study","volume":"27","author":"Sanjuan","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.maturitas.2021.07.009","article-title":"Mucormycosis\u2014An Opportunistic Infection in the Aged Immunocompromised Individual: A Reason for Concern in COVID-19","volume":"154","author":"Chavda","year":"2021","journal-title":"Maturitas"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12281-022-00434-0","article-title":"Overview of COVID-19-Associated Invasive Fungal Infection","volume":"16","author":"Shishido","year":"2022","journal-title":"Curr Fungal Infect Rep"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12281-022-00432-2","article-title":"COVID-19 and Plethora of Fungal Infections","volume":"16","author":"Kundu","year":"2022","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof6040211","article-title":"COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?","volume":"6","author":"Arastehfar","year":"2020","journal-title":"J. Fungi"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3390\/idr13040093","article-title":"Root Causes of Fungal Coinfections in COVID-19 Infected Patients","volume":"13","author":"Amin","year":"2021","journal-title":"Infect. Dis. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A Systematic Review of Cases Reported Worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_14","first-page":"71","article-title":"Invasive Fungal Infections in Patients with COVID-19: A Review on Pathogenesis, Epidemiology, Clinical Features, Treatment, and Outcomes","volume":"44","author":"Chiurlo","year":"2021","journal-title":"New Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"111643","DOI":"10.1016\/j.envres.2021.111643","article-title":"Mucormycosis: An Opportunistic Pathogen during COVID-19","volume":"201","author":"Mahalaxmi","year":"2021","journal-title":"Environ. Res."},{"key":"ref_16","unstructured":"Hern\u00e1ndez, J.L., and Buckley, C.J. (2022). Mucormycosis, StatPearls Publications."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/qjmed\/hcm035","article-title":"Pulmonary Aspergillosis: A Clinical Update","volume":"100","author":"Zmeili","year":"2007","journal-title":"QJM: Int. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Latg\u00e9, J.P., and Chamilos, G. (2020). Aspergillus Fumigatus and Aspergillosis in 2019. Clin. Microbiol. Rev., 33.","DOI":"10.1128\/CMR.00140-18"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus Fumigatus in Invasive Aspergillosis","volume":"22","author":"Dagenais","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40506-014-0016-2","article-title":"Treatment Options in Invasive Aspergillosis","volume":"6","author":"Panackal","year":"2014","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1183\/09031936.02.00256102","article-title":"Diagnosis and Treatment of Invasive Pulmonary Aspergillosis in Neutropenic Patients","volume":"19","author":"Reichenberger","year":"2002","journal-title":"Eur. Respir. J."},{"key":"ref_22","first-page":"160","article-title":"Invasive Aspergillosis","volume":"2","author":"Carter","year":"2017","journal-title":"Spec. Imaging HRCT Lung"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Barantsevich, N., and Barantsevich, E. (2022). Diagnosis and Treatment of Invasive Candidiasis. Antibiotics, 11.","DOI":"10.3390\/antibiotics11060718"},{"key":"ref_24","first-page":"1","article-title":"Invasive Candidiasis; A Review Article","volume":"2","author":"Zarrin","year":"2009","journal-title":"Jundishapur J. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-016-1313-6","article-title":"Diagnosis and Management of Invasive Candidiasis in the ICU: An Updated Approach to an Old Enemy","volume":"20","author":"Calandra","year":"2016","journal-title":"Crit. Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/mmy\/myaa098","article-title":"General Hospital Outbreak of Invasive Candidiasis Due to Azole-Resistant Candida Parapsilosis Associated with an Erg11 Y132F Mutation","volume":"59","author":"Peacock","year":"2021","journal-title":"Med. Mycol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MCC.0b013e32833e046e","article-title":"Pathogenesis of Invasive Candidiasis","volume":"16","author":"Kullberg","year":"2010","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_28","first-page":"1","article-title":"Invasive Candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fcimb.2020.00094","article-title":"Mechanisms of Pathogenic Candida Species to Evade the Host Complement Attack","volume":"10","author":"Singh","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00284-022-02824-6","article-title":"COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies","volume":"79","author":"Ahmed","year":"2022","journal-title":"Curr. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40266-018-0576-9","article-title":"Invasive Candidiasis in the Elderly: Considerations for Drug Therapy","volume":"35","author":"Dekkers","year":"2018","journal-title":"Drugs Aging"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/myc.13332","article-title":"Characteristics of Candidemia in COVID-19 Patients; Increased Incidence, Earlier Occurrence and Higher Mortality Rates Compared to Non-COVID-19 Patients","volume":"64","author":"Kayaaslan","year":"2021","journal-title":"Mycoses"},{"key":"ref_33","first-page":"1199","article-title":"Treatment of Invasive Candidiasis in the Elderly: A Review","volume":"8","author":"Flevari","year":"2013","journal-title":"Clin. Interv. Aging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_35","unstructured":"(2022, November 10). Mucormycosis | Fungal Diseases | CDC, Available online: https:\/\/www.cdc.gov\/fungal\/diseases\/mucormycosis\/index.html."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jiph.2022.10.011","article-title":"Mucormycosis an Added Burden to Covid-19 Patients: An in-Depth Systematic Review","volume":"15","author":"Shah","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 Associated Pulmonary Aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal Co-Infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of Mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_40","first-page":"1","article-title":"COVID-19 Associated Mucormycosis in Assiut University Hospitals: A Multidisciplinary Dilemma","volume":"12","author":"Abdelrady","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_41","unstructured":"(2023, January 14). Centers for Disease Control and Prevention; National Center for Emerging and Zoonotic Infectious Diseases (NCEZID); Division of Foodborne, Waterborne, and Environmental Diseases (DFWED). Fungal Disease- Mucormycosis. Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/fungal\/diseases\/mucormycosis\/."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/abd1806-4841.20176614","article-title":"Cutaneous Mucormycosis","volume":"92","author":"Welsh","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.18231\/j.ijpp.2021.032","article-title":"Mucormycosis: A Manifestation in COVID-19 Infection","volume":"8","author":"Sharma","year":"2021","journal-title":"Indian J. Pharm. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and Clinical Manifestations of Mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","first-page":"40","article-title":"Disseminated Mucormycosis in Healthy Adults","volume":"41","author":"Verma","year":"1995","journal-title":"J. Postgrad. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14740\/jmc3637","article-title":"Rhinocerebral Mucormycosis and COVID-19 Pneumonia","volume":"12","author":"Alekseyev","year":"2021","journal-title":"J. Med. Cases"},{"key":"ref_47","first-page":"140","article-title":"Gastrointestinal Mucormycosis: An Evolving Disease","volume":"8","author":"Spellberg","year":"2012","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kaur, J., Singh, U., Pradhan, U., Singh, G., and Agarwal, P.N. (2021). A Rare Case of Gastrointestinal Mucormycosis. Cureus, 13.","DOI":"10.7759\/cureus.17748"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1148\/rg.2020190156","article-title":"Pulmonary Mucormycosis: Risk Factors, Radiologic Findings, and Pathologic Correlation","volume":"40","author":"Agrawal","year":"2020","journal-title":"Radiographics"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.4187\/respcare.02106","article-title":"Pulmonary Mucormycosis: What Is the Best Strategy for Therapy?","volume":"58","author":"Fernandez","year":"2013","journal-title":"Respir. Care"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"De Macedo, P.M., Freitas, A.D., B\u00e1rtholo, T.P., Bernardes-Engemann, A.R., Almeida, M., and de, A. (2021). Almeida-Silva, F.; Zancop\u00e9-Oliveira, R.M.; Almeida-Paes, R. Acute Pulmonary Histoplasmosis Following COVID-19: Novel Laboratorial Methods Aiding Diagnosis. J. Fungi, 7.","DOI":"10.3390\/jof7050346"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Gerber, V., Ruch, Y., Chamaraux-Tran, T.N., Oulehri, W., Schneider, F., Lindner, V., Greigert, V., Denis, J., Brunet, J., and Danion, F. (2021). Detection of Pneumocystis Jirovecii in Patients with Severe COVID-19: Diagnostic and Therapeutic Challenges. J. Fungi, 7.","DOI":"10.3390\/jof7080585"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s15010-022-01805-y","article-title":"COVID-19-Associated Cryptococcus Infection (CACI): A Review of Literature and Clinical Pearls","volume":"50","author":"Regalla","year":"2022","journal-title":"Infection"},{"key":"ref_54","first-page":"1","article-title":"Cryptococcus Neoformans Meningoencephalitis in an Immunocompetent Patient after COVID-19 Infection","volume":"2021","author":"Ghanem","year":"2021","journal-title":"Case Rep. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e247617","DOI":"10.1136\/bcr-2021-247617","article-title":"Disseminated Histoplasmosis in an Immunocompetent Patient with COVID-19 Pneumonia","volume":"15","author":"Mata","year":"2022","journal-title":"BMJ Case Rep. CP"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/lungindia.lungindia_590_21","article-title":"Acute Localized Pulmonary Histoplasmosis -Another Bug out of COVID\u2019s Pandora Box!","volume":"39","author":"Khanna","year":"2022","journal-title":"Lung India"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3314\/mmj.21-00019","article-title":"Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital","volume":"63","author":"Paul","year":"2022","journal-title":"Med. Mycol. J."},{"key":"ref_58","unstructured":"(2023, January 14). COVID-19-Associated Subacute Invasive Pulmonary Aspergillosis\u2014Swain\u20142022\u2014Mycoses\u2014Wiley Online Library. Available online: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/myc.13369."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/covid2070073","article-title":"COVID-19-Associated Pulmonary Aspergillosis: A Year-Long Retrospective Case Series","volume":"2","author":"Salas","year":"2022","journal-title":"COVID"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s42770-022-00704-6","article-title":"An Overview of COVID-19 Related to Fungal Infections: What Do We Know after the First Year of Pandemic?","volume":"53","author":"Vitale","year":"2022","journal-title":"Braz. J. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19-Associated Fungal Infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat. Microbiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fcimb.2022.850581","article-title":"Recent Advances and Future Directions in the Understanding of Mucormycosis","volume":"12","author":"Garre","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s15010-021-01670-1","article-title":"COVID-19 and Mucormycosis Superinfection: The Perfect Storm","volume":"49","author":"Alhumaid","year":"2021","journal-title":"Infection"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Madhavan, Y., Sai, K.V., Shanmugam, D.K., Manimaran, A., Guruviah, K., Mohanta, Y.K., Venugopal, D.C., Mohanta, T.K., Sharma, N., and Muthupandian, S. (2022). Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives. J. Clin. Med., 11.","DOI":"10.3390\/jcm11133620"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.pt.2021.07.010","article-title":"Pneumocystis Pneumonia in the COVID-19 Pandemic Era: Similarities and Challenges","volume":"37","author":"Matos","year":"2021","journal-title":"Trends Parasitol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.radcr.2022.06.026","article-title":"Concurrent COVID-19 and Pneumocystis Carinii Pneumonia in a Patient Subsequently Found to Have Underlying Hairy Cell Leukemia","volume":"17","author":"Moradians","year":"2022","journal-title":"Radiol. Case Rep."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Jeican, I.I., Ini\u0219ca, P., Gheban, D., T\u0103b\u0103ran, F., Alua\u0219, M., Trombitas, V., Cristea, V., Crivii, C., Junie, L.M., and Albu, S. (2021). COVID-19 and Pneumocystis Jirovecii Pulmonary Coinfection\u2014The First Case Confirmed through Autopsy. Medicina, 57.","DOI":"10.3390\/medicina57040302"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Chastain, D.B., Henao-Mart\u00ednez, A.F., Dykes, A.C., Steele, G.M., Stoudenmire, L.L., Thomas, G.M., Kung, V., and Franco-Paredes, C. (2022). Missed Opportunities to Identify Cryptococcosis in COVID-19 Patients: A Case Report and Literature Review. Ther. Adv. Infect. Dis., 9.","DOI":"10.1177\/20499361211066363"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/myc.13476","article-title":"Cryptococcosis among Hospitalised Patients with COVID-19: A Multicentre Research Network Study","volume":"8","author":"Chastain","year":"2022","journal-title":"Mycoses"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e30143","DOI":"10.1097\/MD.0000000000030143","article-title":"Pulmonary Cryptococcosis after Recovery from COVID-19 in an Immunocompetent Patient: A Rare Case Report","volume":"101","author":"Choi","year":"2022","journal-title":"Medicine"},{"key":"ref_71","first-page":"209","article-title":"COVID-19 Associated with Disseminated Histoplasmosis in a Kidney Transplant Patient","volume":"54","author":"Maldonado","year":"2022","journal-title":"Rev. Argent. Microbiol."},{"key":"ref_72","first-page":"87","article-title":"Microbiological Profile of Post-COVID-19 Mucormycosis in Various Samples","volume":"4","author":"Munipati","year":"2022","journal-title":"Int. J. Sci. Res. Dent. Med. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/myc.13213","article-title":"Invasive Pulmonary Aspergillosis in the COVID-19 Era: An Expected New Entity","volume":"64","author":"Machado","year":"2021","journal-title":"Mycoses"},{"key":"ref_74","unstructured":"(2022, November 10). Fungal Diseases and COVID-19|CDC, Available online: https:\/\/www.cdc.gov\/fungal\/covid-fungal.html."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"03000605211043413","DOI":"10.1177\/03000605211043413","article-title":"Predisposing Factors of Important Invasive Fungal Coinfections in COVID-19 Patients: A Review Article","volume":"49","author":"Zia","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jmv.27358","article-title":"A Systematic Review on SARS-CoV-2-associated Fungal Coinfections","volume":"94","author":"Soni","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_77","unstructured":"Bharadwaj, R., and Thilagavathy, S. (2021). Mucormycosis in COVID-19: A Clinico-Microbiological Dilemma. Kauverian Sci. J., 2."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"108409","DOI":"10.1016\/j.clim.2020.108409","article-title":"Individual Risk Management Strategy and Potential Therapeutic Options for the COVID-19 Pandemic","volume":"215","author":"Gasmi","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"197989","DOI":"10.1016\/j.virusres.2020.197989","article-title":"Natural Product-Derived Phytochemicals as Potential Agents against Coronaviruses: A Review","volume":"284","author":"Mani","year":"2020","journal-title":"Virus Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clnesp.2020.06.003","article-title":"The Key Role of Zinc in Elderly Immunity: A Possible Approach in the COVID-19 Crisis","volume":"38","year":"2020","journal-title":"Clin. Nutr. Espen"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114520003128","article-title":"Selenium and Viral Infection: Are There Lessons for COVID-19?","volume":"125","author":"Bermano","year":"2021","journal-title":"Br. J. Nutr."},{"key":"ref_82","first-page":"7869","article-title":"The Impact of COVID-19 on Doctors\u2019 Well-Being: Results of a Web Survey during the Lockdown in Italy","volume":"24","author":"Sio","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Anca, P.S., Toth, P.P., Kempler, P., and Rizzo, M. (2021). Gender Differences in the Battle against COVID-19: Impact of Genetics, Comorbidities, Inflammation and Lifestyle on Differences in Outcomes. Int. J. Clin. Pract., 75.","DOI":"10.1111\/ijcp.13666"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12011-021-02623-3","article-title":"The Role of Diet and Supplementation of Natural Products in COVID-19 Prevention","volume":"200","author":"Gasmi","year":"2022","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"126734","DOI":"10.1016\/j.physa.2021.126734","article-title":"A Dynamic Physical-Distancing Model to Evaluate Spatial Measures for Prevention of Covid-19 Spread","volume":"592","author":"Xiao","year":"2022","journal-title":"Phys. A Stat. Mech. Its Appl."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"118273","DOI":"10.1016\/j.envpol.2021.118273","article-title":"Prevention and Control of Coronavirus Disease 2019 (COVID-19) in Public Places","volume":"292","author":"Pan","year":"2022","journal-title":"Environ. Pollut."},{"key":"ref_87","first-page":"5668","article-title":"Identification of Bioactive Molecule from Withania Somnifera (Ashwagandha) as SARS-CoV-2 Main Protease Inhibitor","volume":"1","author":"Tripathi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.dsx.2020.04.015","article-title":"Enhancing Immunity in Viral Infections, with Special Emphasis on COVID-19: A Review","volume":"14","author":"Jayawardena","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"108725","DOI":"10.1016\/j.clim.2021.108725","article-title":"The Microbiota-Mediated Dietary and Nutritional Interventions for COVID-19","volume":"226","author":"Gasmi","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.clnu.2020.03.022","article-title":"ESPEN Expert Statements and Practical Guidance for Nutritional Management of Individuals with SARS-CoV-2 Infection","volume":"39","author":"Barazzoni","year":"2020","journal-title":"Clin. Nutr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jinf.2014.01.005","article-title":"Serum Galactomannan Antigen Test for the Diagnosis of Chronic Pulmonary Aspergillosis","volume":"68","author":"Shin","year":"2014","journal-title":"J. Infect."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CMR.00091-13","article-title":"Molecular and Nonmolecular Diagnostic Methods for Invasive Fungal Infections","volume":"27","author":"Arvanitis","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_93","first-page":"195","article-title":"Opportunistic Invasive Fungal Infections: Diagnosis & Clinical Management","volume":"139","author":"Badiee","year":"2014","journal-title":"Indian J. Med. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jiph.2022.02.007","article-title":"Mucormycosis and COVID-19 Pandemic: Clinical and Diagnostic Approach","volume":"15","author":"Azhar","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"a019299","DOI":"10.1101\/cshperspect.a019299","article-title":"Fungal Diagnostics","volume":"4","author":"Kozel","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/512812","article-title":"Comparison of Histopathological Analysis, Culture, and Polymerase Chain Reaction Assays to Detect Invasive Mold Infections from Biopsy Specimens","volume":"44","author":"Rickerts","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/acssensors.0c02621","article-title":"COVID-19 Antibody Tests and Their Limitations","volume":"6","author":"Liu","year":"2021","journal-title":"ACS Sens."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3389\/fmicb.2015.00791","article-title":"MALDI-TOF Mass Spectrometry: An Emerging Technology for Microbial Identification and Diagnosis","volume":"6","author":"Singhal","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"FSO819","DOI":"10.2144\/fsoa-2022-0011","article-title":"Co-Infection Associated with SARS-CoV-2 and Their Management","volume":"8","author":"Chavda","year":"2022","journal-title":"Futur. Sci. OA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1021\/acssensors.0c02312","article-title":"CRISPR Systems for COVID-19 Diagnosis","volume":"6","author":"Rahimi","year":"2021","journal-title":"ACS Sens."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/JCM.01737-13","article-title":"\u03b2-d-Glucan Testing Is Important for Diagnosis of Invasive Fungal Infections","volume":"51","author":"Theel","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1128\/JCM.02430-16","article-title":"Laboratory Diagnostics for Histoplasmosis","volume":"55","author":"Azar","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_103","first-page":"CD012399","article-title":"Galactomannan Detection in Broncho-alveolar Lavage Fluid for Invasive Aspergillosis in Immunocompromised Patients","volume":"2019","author":"Gerritsen","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1378\/chest.10-0488","article-title":"Accuracy of BAL Galactomannan in Diagnosing Invasive Aspergillosis: A Bivariate Metaanalysis and Systematic Review","volume":"138","author":"Guo","year":"2010","journal-title":"CHEST"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2174\/156802662022200917110102","article-title":"Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options","volume":"20","author":"Silva","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_106","unstructured":"(2023, January 14). Treatment for Aspergillosis|Aspergillosis|Types of Fungal Diseases|Fungal Diseases|CDC, Available online: https:\/\/www.cdc.gov\/fungal\/diseases\/aspergillosis\/treatment.html."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1128\/AAC.00701-16","article-title":"Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin","volume":"60","author":"Ong","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_108","unstructured":"(2023, January 14). Treatment|Invasive Candidiasis|Candidiasis|Types of Diseases|Fungal Diseases|CDC, Available online: https:\/\/www.cdc.gov\/fungal\/diseases\/candidiasis\/invasive\/treatment.html."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1164\/rccm.202003-0766LE","article-title":"A Case of COVID-19 and Pneumocystis Jirovecii Coinfection","volume":"202","author":"Menon","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/599105","article-title":"Recent Advances in the Management of Mucormycosis: From Bench to Bedside","volume":"48","author":"Goldstein","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Ellsworth, M., and Ostrosky-Zeichner, L. (2020). Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance. J. Fungi, 6.","DOI":"10.3390\/jof6040324"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4037\/ccn2022237","article-title":"A Care Step Pathway for the Diagnosis and Treatment of COVID-19-Associated Invasive Fungal Infections in the Intensive Care Unit","volume":"42","author":"Jones","year":"2022","journal-title":"Crit. Care Nurse"},{"key":"ref_113","first-page":"2118","article-title":"COVID-19-Associated Fungal Infections: An Urgent Need for Alternative Therapeutic Approach?","volume":"13","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_114","unstructured":"Hempel, G. (2020). Methods of Therapeutic Drug Monitoring Including Pharmacogenetics, Elsevier."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Jenks, J.D., and Hoenigl, M. (2018). Treatment of Aspergillosis. J. Fungi, 4.","DOI":"10.3390\/jof4030098"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s40265-016-0652-6","article-title":"Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis","volume":"76","author":"Shirley","year":"2016","journal-title":"Drugs"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2147\/DDDT.S145545","article-title":"Spotlight on Isavuconazole in the Treatment of Invasive Aspergillosis and Mucormycosis: Design, Development, and Place in Therapy","volume":"12","author":"Jenks","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/08998280.2007.11928283","article-title":"Posaconazole (Noxafil): A New Triazole Antifungal Agent","volume":"Volume 20","author":"Greer","year":"2007","journal-title":"Baylor University Medical Center Proceedings"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/TP.0b013e3181837585","article-title":"Posaconazole as Salvage Therapy in Patients with Invasive Fungal Infections After Solid Organ Transplant","volume":"86","author":"Alexander","year":"2008","journal-title":"Transplantation"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_121","unstructured":"(2023, January 14). Liposomal Amphotericin B (AmBisome\u00ae) Efficacy in Confirmed Invasive Aspergillosis and Other Filamentous Fungal Infections in Immunocompromised Hosts: A Pooled Analysis\u2014Cordonnier\u20142007\u2014Mycoses\u2014Wiley Online Library. Available online: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2007.01362.x."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/myc.12759","article-title":"Surveillance for Azoles Resistance in Aspergillus spp. Highlights a High Number of Amphotericin B-Resistant Isolates","volume":"61","author":"Lyra","year":"2018","journal-title":"Mycoses"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof6030163","article-title":"Pan-Echinocandin-Resistant Candida Glabrata Bloodstream Infection Complicating COVID-19: A Fatal Case Report","volume":"6","author":"Posteraro","year":"2020","journal-title":"J. Fungi"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Ben-Ami, R. (2018). Treatment of Invasive Candidiasis: A Narrative Review. J. Fungi, 4.","DOI":"10.3390\/jof4030097"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/fmb-2020-0217","article-title":"Rezafungin: A Novel Antifungal for the Treatment of Invasive Candidiasis","volume":"16","author":"Ham","year":"2021","journal-title":"Future Microbiol."},{"key":"ref_126","unstructured":"Govindarajan, A., Bistas, K.G., Ingold, C.J., and Aboeed, A. (2022). Fluconazole. Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, StatPearls Publishing. [7th ed.]."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole Resistance in Candida Species: A Current Perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"IDR"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Delma, F.Z., Al-Hatmi, A.M.S., Br\u00fcggemann, R.J.M., Melchers, W.J.G., de Hoog, S., Verweij, P.E., and Buil, J.B. (2021). Molecular Mechanisms of 5-Fluorocytosine Resistance in Yeasts and Filamentous Fungi. J. Fungi, 7.","DOI":"10.3390\/jof7110909"},{"key":"ref_129","first-page":"86","article-title":"Flucytosine: Correlation between Toxicity and Pharmacokinetic Parameters","volume":"46","author":"Vermes","year":"2000","journal-title":"CHE"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4103\/1995-7645.326253","article-title":"COVID-19-Associated Mucormycosis and Treatments","volume":"14","author":"Subramaniyan","year":"2021","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective Pilot Study of High-Dose (10 Mg\/Kg\/Day) Liposomal Amphotericin B (L-AMB) for the Initial Treatment of Mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1586\/17512433.2015.1034689","article-title":"Pharmacologic and Clinical Evaluation of Posaconazole","volume":"8","author":"Moore","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/phar.1652","article-title":"Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent","volume":"35","author":"Rybak","year":"2015","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Smith, C., and Lee, S.C. (2022). Current Treatments against Mucormycosis and Future Directions. PLOS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010858"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the Diagnosis and Treatment of Mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Maertens, J., Egerer, G., Shin, W.S., Reichert, D., Stek, M., Chandwani, S., Shivaprakash, M., and Viscoli, C. (2010). Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis: Results of a Prospective Observational Registry. BMC Infect. Dis., 10.","DOI":"10.1186\/1471-2334-10-182"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/jim-2021-002179","article-title":"Utility of Itraconazole and Terbinafine in Mucormycosis: A Proof-of-Concept Analysis","volume":"70","author":"Gupta","year":"2022","journal-title":"J. Investig. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/3\/555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:43:59Z","timestamp":1760121839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/3\/555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":138,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["vaccines11030555"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11030555","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]}}}